<VariationArchive RecordType="classified" VariationID="11132" VariationName="NM_000377.3(WAS):c.11del (p.Gly4fs)" VariationType="Deletion" Accession="VCV000011132" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2018-12-15" MostRecentSubmission="2020-07-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26171" VariationID="11132">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000377.3(WAS):c.11del (p.Gly4fs)</Name>
      <CanonicalSPDI>NC_000023.11:48683859:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48683860" stop="48683860" display_start="48683860" display_stop="48683860" variantLength="1" positionVCF="48683859" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542249" stop="48542249" display_start="48542249" display_stop="48542249" variantLength="1" positionVCF="48542248" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G4fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48542253del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48542253del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48683864del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48683864del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007877.1" sequenceAccession="NG_007877" sequenceVersion="1" change="g.5068del">
            <Expression>NG_007877.1:g.5068del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.11del" MANESelect="true">
            <Expression>NM_000377.3:c.11del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000368.1" sequenceAccession="NP_000368" sequenceVersion="1" change="p.Gly4fs">
            <Expression>NP_000368.1:p.Gly4fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_125" sequenceAccession="LRG_125">
            <Expression>LRG_125:g.5068del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_125t1" sequenceAccession="LRG_125t1">
            <Expression>LRG_125t1:c.11del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_125p1" sequenceAccession="LRG_125p1" change="p.Gly4fs">
            <Expression>LRG_125p1:p.Gly4fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA341015" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300392.0019" DB="OMIM" />
        <XRef Type="rs" ID="587776745" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000377.3(WAS):c.11del (p.Gly4fs) AND Wiskott-Aldrich syndrome" Accession="RCV000011882" Version="8">
        <ClassifiedConditionList TraitSetID="3075">
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000377.3(WAS):c.11del (p.Gly4fs) AND multiple conditions" Accession="RCV001225126" Version="1">
        <ClassifiedConditionList TraitSetID="11545">
          <ClassifiedCondition DB="MedGen" ID="C1839163">Thrombocytopenia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1845987">X-linked severe congenital neutropenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-12-15" MostRecentSubmission="2020-07-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10653325</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16511828</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6046" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">THROMBOCYTOPENIA, X-LINKED, 1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked thrombocytopenia with normal platelets</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombocytopenia, X-linked</ElementValue>
                <XRef ID="Thrombocytopenia%2C+x-linked/7084" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia 1</ElementValue>
                <XRef ID="MONDO:0010743" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THC</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WAS/XLT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLT</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5176" />
                <XRef ID="5176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="268322" DB="Orphanet" />
              <XRef ID="852" DB="Orphanet" />
              <XRef ID="C1839163" DB="MedGen" />
              <XRef ID="MONDO:0010743" DB="MONDO" />
              <XRef Type="MIM" ID="313900" DB="OMIM" />
            </Trait>
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
            <Trait ID="5640" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked severe congenital neutropenia</ElementValue>
                <XRef ID="MONDO:0010294" DB="MONDO" />
                <XRef ID="718882006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCNX</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLN</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3981" />
                <XRef ID="3981" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="86788" DB="Orphanet" />
              <XRef ID="C1845987" DB="MedGen" />
              <XRef ID="MONDO:0010294" DB="MONDO" />
              <XRef Type="MIM" ID="300299" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3075" Type="Disease">
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32115" SubmissionDate="2018-01-16" DateLastUpdated="2018-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300392.0019_WISKOTT-ALDRICH SYNDROME" title="WAS, 1-BP DEL, 11G_WISKOTT-ALDRICH SYNDROME" />
        <ClinVarAccession Accession="SCV000032115" DateUpdated="2018-12-15" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Du et al. (2006) described somatic mosaicism in a 15-year-old Wiskott-Aldrich syndrome (WAS; 301000) patient due to a second-hit mutation in the initiation codon of the WAS gene. The germline mutation was a single-basepair deletion in the WAS cDNA, 11delG, which resulted in a frameshift and abrogated protein expression (Gly4fsTer40). The patient had originally been described by Sasahara et al. (2000). Seven years after chemotherapy for Hodgkin disease, expression of WASP was detected in a fraction of T and NK cells. These WASP-expressing cells had a 1A-T (M1_P5del) mutation in the initiation codon. Du et al. (2006) hypothesized that the second-site mutation in the initiation codon resulted in alternative translation initiation from the second ATG that is located downstream of the germline single-nucleotide deletion. The patient was in complete remission at the time of the report of Du et al. (2006).</Attribute>
              <Citation>
                <ID Source="PubMed">16511828</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10653325</ID>
              </Citation>
              <XRef DB="OMIM" ID="301000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <Name>WAS, 1-BP DEL, 11G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 11G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300392.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WISKOTT-ALDRICH SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2732309" SubmissionDate="2020-02-06" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4971037|MedGen:C0043194;C1845987;C1839163" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001397364" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10653325</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly4Alafs*41) in the WAS gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with Wiskott-Aldrich syndrome (PMID: 10653325). This variant is also known as 45delG in the literature. ClinVar contains an entry for this variant (Variation ID: 11132). Loss-of-function variants in WAS are known to be pathogenic (PMID: 15284122). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000377.2:c.11del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">X-linked severe congenital neutropenia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1845987" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">X-linked thrombocytopenia with normal platelets</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1839163" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2732309" TraitType="Disease" MappingType="Name" MappingValue="Wiskott-Aldrich syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32115" TraitType="Disease" MappingType="Name" MappingValue="WISKOTT-ALDRICH SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2732309" TraitType="Disease" MappingType="Name" MappingValue="X-linked thrombocytopenia with normal platelets" MappingRef="Preferred">
        <MedGen CUI="C1839163" Name="Thrombocytopenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2732309" TraitType="Disease" MappingType="Name" MappingValue="X-linked severe congenital neutropenia" MappingRef="Preferred">
        <MedGen CUI="C1845987" Name="X-linked severe congenital neutropenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

